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A cobalt-rhodium heterobimetallic nanoparticle-catalyzed reductive 
cyclization of 2-(2-nitroaryl)acetonitriles to indoles has been 
achieved. The tandem reaction proceeds without any additives under 
the mild conditions (1 atm H2 and 25 
oC). This procedure could be 
scaled up to the gram scale. The catalytic system is significantly 
stable under these reaction conditions and could be reused more 
than ten times without loss of catalytic activity. 
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Indoles1 are ubiquitous structural units of biologically active 
natural products and pharmaceutical compounds. The synthesis of 
indoles has attracted substantial attention, and a number of useful 
synthetic methods for indoles have been developed, established, and 
reviewed.2 However, the scope and generality of the synthesis of a 
particular indole have sometimes been restricted owing to the lack 
of substrate availability. Consequently, the development of efficient 
and atom-economical methods for the synthesis of indoles from 
readily available starting materials is still challenging. From this 
perspective, 2-(2-nitroaryl)acetonitriles3 could be good candidates 
because they are easily obtained from commercially available 
starting materials and thus might be suitable substrates for the 
synthesis of 3 to 7-substituted indoles. It has been especially 
reported4 that C3-arylindoles exhibit important biological 
responses. In fact, the use of 2-(2-nitroary1)acetonitriles in the 
synthesis of indoles has been well-established.5 For example, 
Mąkosza reported6 the reduction of 2-(2-nitroaryl)acetonitriles in 
the presence of palladium on activated charcoal to the corresponding 
indoles in moderate to high yields (Scheme 1, eq 1). However, the 
reaction was very complicated and sensitive to the reaction 
conditions because the reaction should be carried out in an acidic 
condition and relatively high pressure where mixture solvent of 
ethanol and acetic acid (5:1) and 3 atm of hydrogen gas were used 
together. Nagashima also reported7 the reaction of 2-
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nitrophenylacetonitriles with the heterogeneous platinum catalyst 
[Pt]@SiC6 affording a reductive cyclization product, indole, with 
52% yield (Scheme 1, eq. 2), but the reaction required 10 atm of 
hydrogen which is much higher than the pressure used for 
Mąkosza’s reaction.  
 
Scheme 1. Catalytic synthesis of indoles  
 
 
Although the use of (2-nitroaryl)acetonitriles as substrates has 
been revealed as an attractive method for the synthesis of indoles, 
nevertheless, it has been rarely used for the purpose of indole 
synthesis in a direct way. Instead, as an indirect way, 2-(2-
aminoaryl)acetonitriles, prepared by the reduction of 2-(2-
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nitroaryl)acetonitriles, has been most commonly used in the 
conversion to indoles (Scheme1, eq. 3 and eq. 4).8 Therefore, we 
were interested in reevaluation for a direct way of use of 2-
nitrophenylacetonitriles in the synthesis of indoles by simple 
hydrogenation. 
Recently, the use of heterobimetallic nanoparticles as catalysts has 
attracted much attention because of their superior catalytic 
performance compared to that of monometallic nanoparticles.9 We 
reported that cobalt/rhodium heterobimetallic nanoparticles (Co2Rh2, 
derived from Co2Rh2(CO)12) immobilized on charcoal (Co2Rh2/C) 
showed wide usefulness for Pauson-Khand reaction10 and 
hydrogenation of nitroarenes.11 Hoping to find a new catalytic 
reaction, we found that Co2Rh2/C could be used for reductive 
cyclization of 2-(2-nitroaryl)acetonitriles under atmospheric 
hydrogen at room temperature, leading to the isolation of indoles 
with high yields (eq 5). We herein report our results that the 
reductive cyclization with Co2Rh2/C could be conducted under 
substantially lower pressure, atmospheric hydrogen, and could be 
reused more than ten times without loss of catalytic activities. As 
far as we are aware, this is the first report of indoles and azaindoles 




Result and Discussion 
 
  Initially, we studied the hydrogenation of benzonitrile under 1 atm 
of hydrogen (a balloon of hydrogen) at ambient temperature in the 
presence of Co2Rh2/C (Table 1). Benzonitrile was easily converted 
to benzyl amine, N-benzyl-1-phenylmethanimine, and dibenzyl 
amine. Because of the high reactivity of Co2Rh2/C in the 
hydrogenation reaction, it was difficult to stop the reaction at the 
stage of a specific product.  
 
Table 1. Screening data for benzonitriles reduction 
 
  However, depending on the arene nitrile substrate itself and 







A B C 
1 p-Xylene 18 25 0 4 67 
2 EtOH 18 25 0 76 trace 
3 MeOH 18 25 0 trace 60 
4 p-Xylene 3 70 10 17 48 
5 EtOH 3 70 5 55 5 
6 MeOH 3 70 trace 95 trace 
a3 mL used. bGC yield using mesitylene as internal standard. 
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the major product (Table 2). Therefore, we confirmed that nitrile 
groups could be easily reduced in the presence of a catalytic amount 
of Co2Rh2/C under atmospheric hydrogen. It is notable that the easy 
formation of secondary amine or imine under mild reaction 
conditions is remakable.12  
 
Table 2. Substrate scopes of various arene nitriles reduction 
 
  Encouraged by these observations, we began to investigate the 
reductive cyclization of 2-(2-nitroaryl)acetonitriles. The reaction 
conditions were optimized using 0.25 mmol of substrate with 5 mol % 









A B C 
1 4-Cl 100 8 92 0 
2 4-F 83 3 97 0 
3 4-OMe 100 4 85 10 
4 2-Cl 100 14 66 20 
a Selectivity detected by GC-Mass. 
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Isolated Yield  (%) 
(A / B / C) 
1 MeOH 24 5 75 (68 / 7 / 0) 
2 THF 24 5 57 (57 / 0 / 0) 
3 CH2Cl2 24 5 54 (54 / 0 / 0) 
4 Benzene 24 5 24 (24 / 0 / 0) 
5 Toluene 24 5 57 (57 / 0 / 0) 
6 p-Xylene 24 5 60 (60 / 0 / 0) 
7 MeOH 24 1 62 (10 / 0 / 52) 
8 MeOH 24 10 70 (34/ 36 / 0) 
9 MeOH 3 5 42 (42 / trace / 0) 
10 MeOH 8 5 61 (57/ 4 / 0) 
11 MeOH 16 5 69 (62 / 7 / 0) 
12 MeOH 24 5 68(63 / 5 / 0) 
13 wet MeOH 24 5 76 (70 / 6 / 0) 
a
3 mL used. 
b




  As an initial step, we tried to conduct this reaction with 
nitrophenyl)acetonitrile, 2-(2-nitrophenyl)propanenitrile, and 2-
(2-Nitrophenyl)butanenitrile as a substrate. However, three of 
corresponding products went through sublimation as dried in vacuo, 
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so that we could not detect an exact yield of each reaction. When we 
used 2-(5-bromo-2-nitrophenyl)acetonitrile as a substrate, a 
corresponding product, 5-bromo-1H-indole, was isolated without 
sublimation even after a day during dryness in vacuo. With 2-(5-
bromo-2-nitrophenyl)acetonitrile as a model substrate, we 
screened the reaction medium (Table 3, entries 1-6), and 
reasonable yields were observed for all solvents used. The highest 
total yield of reductive cyclization products (75%) was observed 
with methanol, and a debromination product, 1H-indole (B), was 
isolated in no more than 7% yield. Using methanol as a 
representative reaction solvent, we examined how the reaction 
depended on the amount of Co2Rh2/C used (entry 1 vs 7 and 8). 
Decreasing the amount of the catalyst from 5 mol % to 1 mol % led 
to the formation of a mixture of 5-bromoindole (A) and 2-(2-
aminophenyl)acetonitrile (C) in 10% and 52% yield, respectively 
(entry 7). When the amount of the catalyst increased from 5 mol % 
to 10 mol %, formation of A and B in 34% and 36% yield, 
respectively, was observed (entry 8). Decreasing the reaction time 
from 24 h to 3, 8, and 16 h resulted in the isolation of cyclization 
product in 42%, 61%, and 69% yields, respectively (entries 9-11). 
When a reaction was conducted at 50 oC, A and B were isolated in 
63% and 5% yields, respectively (entry 12). To our delight, when 
the reaction was conducted in wet methanol, a similar high yield, 
76%, to the reaction conducted in dry methanol was observed (entry 
13). This means that the solvent (MeOH) could be used without 
purification, allowing the catalytic system to be operationally simple. 
10 
 
Other metal nanoparticles, such as Co/C and Rh/C, were examined as 
a catalyst using 2-(2-nitrophenyl)acetonitrile as a substrate 
(Scheme 2). In a case of Co/C, no reaction was observed. 
Interestingly, Rh/C showed a high catalytic activity in the reductive 
cyclization of 2-(2-nitrophenyl)acetonitrile, but no desirable 
product was obtained in the reaction of 2-(6-methoxy-3-
nitropyridin-2-yl)acetonitrile. Among the catalysts studied, no 
other case gave a higher yield and wider substrate scope than 
Co2Rh2/C. used.  
 




Thus, the optimum reaction conditions for the reductive cyclization 
were temporary established as follows: 0.25 mmol of substrates, 5 
mol % Co2Rh2/C in 3.0 mL MeOH at 25 













R1 R2 R3 
1 H H H 68 (2a) 
2 Me H H 80 (2b) 
3 Et H H 97 (2c) 
4 Pr H H 81 (2d) 
5 Ph H H 83 (2e) 
6 4-FC6H4 H H 86 (2f) 
7 4-ClC6H4 H H 71 (2g) 
8 4-MeOC6H4 H H 78 (2h) 
9 CH2Ph H H 27 (49)
b (2i) 
10 Cl H H 56c (2j) 
11 H F H 71 (2k) 
12 H Cl H 73 (2l) 
13 Me Cl H 76 (2m) 
14 Pr Cl H 89 (2n) 
15 H H Cl 71 (2o) 
16 (CO)OEt H Cl 91 (2p) 
17 Me Br H 78 (2q) 
18 Pr Br H 53 (2r) 
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19 (CO)OEt H Br 92 (2s) 
20 H CF3 H 49 (2t) 
21 H H CF3 73 (2u) 
22 H OMe H 68 (2v) 
23 Me OMe H 90 (2w) 
24 Pr OMe H 73 (2x) 
25 H OMe OMe 59 (2y) 





a Isolated yield. b When the reaction proceeded for 48 h, a yield was 
49%. c 1H-indole was isolated. An isolated product was 2-(1H-
indol-3-yl)aniline. 
 
  With the optimized reaction conditions in hand, the substrate scope 
of the reaction was next examined (Table 4). The reductive 
cyclization reaction showed excellent generality for a variety of 2-
(2-nitroaryl)acetonitriles substrates. In some cases, sublimation, 
dehalogenation, and steric hindrance might have a slightly 
unfavorable effect on the yield. For example, because some indoles 
suffered from sublimation while drying in vacuo, their isolated yields 
were not as great as we expected. With regard to dehalogenation, 
bromo-substituted starting materials were merely undergone 
(entries 17-19). Chloro group at the  position to the nitrile was 
intolerant likewise under our reaction conditions (entry 10), yielding 
1H-indole as the sole product. 3-Benzyl-1H-indole showed low 
yield (27%), but this could be overcome and approximately doubled 
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by lengthening the reaction time (entry 9, 48 h). This result 
presumably occurred due to the benzyl group, hampering 
coordination to the nanoparticles as proposed by Sajiki et al.8a 
Beside these observations above, for overall – substituted 2-(2-
nitrophenyl)acetonitrile, the corresponding indoles were isolated in 
high to excellent yields (71-97%) (entries 2-8). Moreover, the 
halo (F and Cl) substituents in 2-(5-halo-2-nitrophenyl)aceto-
nitriles and 2-(6-halo-2-nitrophenyl)acetonitriles were generally 
survived (entries 11-16). The corresponding products were 
isolated in reasonable to high yields (71-91%). In general, both 
electron-donating (OMe) and withdrawing (F, Cl, Br, CF3) groups 
on the aromatic substituents of the substrates are tolerated (entries 
11-25). When 2,2-bis(2-nitrophenyl)acetonitrile was used as a 
substrate, 2-(1H-indol-3-yl)aniline, widely used in the synthesis 
of indolo[2,3-c]quinolines,13 was isolated in 79% yield (entry 26). 
Treatment of 2-(1-nitronaphthalen-2-yl)acetonitrile with 
hydrogen afforded 1H-benzo[g]indole in 77% yield. This presents 
the first synthesis of 1H-benzo[g]indole from the substrate having 
both a nitrile and a nitro group via the reductive cyclization (entry 
27). In addition, we tested several modified versions of this reaction 
under the optimized condition (Scheme 3). Thiophene derivatives 
could not show a cyclized product, 6H-thieno[2,3-b]pyrrole 
(Scheme 3, eq 1). Also, we expected that relatively remote 
positioned nitriles could be attacked by amines reduced from nitro 
group, which producing 1,4-dihydroquinoline, but we could not 
isolated the desired product (Scheme 3, eq 2). Lastly, we 
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anticipated that hydroxyl group could attack nitrile group followed 
by removal of NH3, making benzofuran, but unfortunately, we could 
not obtain the expected product (Scheme 3, eq 3). 
 
Scheme 3. Modified version of this reaction 
 
 
  To test electronic effects, (5-methoxy-2-nitrophenyl)-2-(2-
nitrophenyl)acetonitrile and 2-(5-chloro-2-nitrophenyl)-2-(2-
nitrophenyl)acetonitrile, were prepared and reacted under our 
reaction conditions (Scheme 4). Notably, an aromatic group with an 
electron-donating group (OMe) gave three times more cyclization 
product than an aromatic group without a methoxy group. In the first 
reaction, 2-(5-methoxy-1H-indol-3-yl)aniline and 2-(1H-
indol-3-yl)-4-methoxyaniline were isolated in 65% and 21% yield, 
respectively. In the second reaction, 2-(5-chloro-1H-indol-3-
yl)aniline, and 4-chloro-2-(1H-indol-3-yl)aniline were isolated 
in 22% and 49% yields, respectively. This observation clearly 
demonstrated that the electron-richness of substituent favors the 




Scheme 4. Competition experiments 
  
 
    In addition, the reaction could be conducted on a gram-scale 
(Scheme 5). 1.58 g of 1H-indole, was isolated in 65% yield from 2-
(2-nitrophenyl)acetonitrile. Thus, it was proved that scale-up of 
the procedure resulted in no reduction in the yield. 
 
Scheme 5. Gram-scale experiment 
 
 
  Azaindoles possess remarkable pharmacological and 
physicochemical properties, although their direct functionalization at 
the C3 position is not straightforward.14 Thus, we investigated the 
reductive cyclization of 2-(3-nitropyridin-2-yl)acetonitrile 
derivatives under our mild conditions (Table 5). Pyridine derivatives 
were then hydrogenated to provide the corresponding C3-
16 
 
substituted 4-azaindoles in high yields (61-72%).  
 
Table 5. Synthesis of Azaindoles 
 
entry Reactant isolated yield (%)a 
1 R = H 61 (4a) 
2 R = Me 72 (4b) 
3 R = Pr 67 (4c) 
4 R = CH2(CO)OEt 65 (4d) 
 
  Thus, the catalytic reaction process developed in this study 
revealed a greatly easy and simple way to make both indoles and 
azaindoles under the user-friendly condition (1 atm H2 and 25 
oC).  
  Recyclability is one of the strong points for heterogeneous 
catalysts. Therefore, the reusability of Co2Rh2/C was examined for 
the reductive cyclization of 2-(2-nitrophenyl)acetonitrile (Figure 
1). After each reaction, the catalyst was separated from the reaction 
mixture by centrifuge, dried in vacuum, and then reused for the 
further catalytic reactions. For ten runs, 68%, 69%, 69%, 67%, 47%, 
66%, 67%, 66%, 67%, and 65%, yields were shown respectively. 
The conversion rate for each cycle was almost quantitative, but the 
isolated yield for each cycle was not particularly high due to the 
sublimation effect as mentioned above. According to the GC-Mass 
analysis of the reaction products, no major byproducts were formed 
17 
 
except a trace amount of 2-(2-aminophenyl)acetonitrile. Strangely, 
at the fifth cycle, the formation of 2-(2-aminophenyl)acetonitrile 
(10%) was observed; however, the catalytic activity was restored in 
the subsequent cycle. This suggested an experimental error at the 
fifth cycle. The reductive cyclization of 2-(2-
nitrophenyl)butanenitrile under the same reaction conditions was 
also tested as below after the ten runs, showing that the catalyst 
was still highly stable with other substrates under our reaction 
conditions. Therefore, the catalytic system showed a great 
capability of reuse and a significant air-stability under the reaction 
conditions.  
 
Figure 1. Reuse of Co2Rh2/C in the Synthesis of Indoles 
 
 
  To obtain an insight on the reaction mechanism, we monitored the 
reaction intermediate generated in the reductive cyclization of 2-
18 
 
(2-nitrophenyl)acetonitrile by GC-Mass (Figure 2). Initially, rapid 
consumption of 2-(2-nitrophenyl)acetonitrile (blue line) along with 
the formation of 2-(2-aminophenyl)acetonitrile (purple line) was 
observed. As time passed, the concentration of 1H-indole (red line) 
increased and that of 2-(2-aminophenyl)acetonitrile decreased. At 
the later stage, the formation of 2-(2-aminoethyl)aniline (green 
line) was observed and slowly increased; however, its amount was 
negligible.  
 




  Based on these results, plausible reaction pathways were proposed 
(Scheme 6). Although we failed to detect the intermediate amidine 
or imine, two pathways could be proposed. Pathway 1 included the 
nucleophilic attack of amine on the nitrile carbon, resulting in the 
formation of amidine (C). Nitriles were presumably activated by the 
coordination of Co-Rh heterobimetallic nanoparticle as proposed by 
Sajiki et al.8 Pathway 2 proceeded via an imine intermediate (D). 
According to our study on the nitrile reduction, nitriles in MeOH 
19 
 
were easily reduced to an imine at room temperature in the 
presence of Co2Rh2/C. Thus, the generated imine intermediate could 
be readily attacked by an amine to form a cyclized intermediate (F). 
This pathway could also lead to the formation of 2-(2-
aminoethyl)aniline (E) detected during the GC-Mass monitoring. 
 






We have developed an operationally simple, highly active, and 
recyclable method for the Co2Rh2 nanoparticles/charcoal-catalyzed 
cascade reductive cyclization of (2-nitroaryl)acetonitriles to indoles 
and 2-(3-nitropyridin-2-yl)acetonitrile to azaindoles within 24 h. 
To the best of our knowledge, this is the first report of indoles and 
azaindoles synthesis under only 1 atm of hydrogen at room 
temperature. Advantageously, no complicated ligands or additional 
acid or base is needed. The experimental simplicity and reusability 
(more than ten times) are especially attractive features of the 
catalytic system and should encourage its use among synthetic 
chemists. Further investigations of the present catalytic system for 






1. General Remarks 
  Workup procedures were done in air. All solvents were used 
without further purification. Unless otherwise noted, all commercial 
materials were used without purification. Reagents were purchased 
from Sigma-Aldrich, Alfa Aesar, Acros, and TCI and were used as 
received. High purity H2 (99.999%) was used. TLC analysis of 
reaction mixtures was performed on Merck silica gel 60 F254 TLC 
plates. TLC plates were visualized by ultraviolet light and treated 
with acidic p-anisaldehyde stain followed by gentle heating. Flash 
column chromatography was carried out on Merck 60 silica gel 
(230-400 mesh). 1H NMR, 13C NMR, 19F NMR spectra were 
recorded with Agilent 400-MR DD2 (400 MHz, 100 MHz, and 376 
MHz respectively) and 1H NMR, 13C NMR spectra were recorded 
with Varian (500 MHz and 125 MHz, respectively) spectrometer. 1H 
NMR spectra were taken in CDCl3 and were referenced to residual 
TMS (0 ppm) and reported as follows: chemical shift (δ ppm), 
multiplicity (s = singlet, d= doublet, t = triplet, q = quartet, m = 
multiplet), coupling constant (Hz), and integration. Chemical shifts of 
the 13C NMR spectra were measured relative to CDCl3 (77.16 ppm) 
and DMSO-d6 (39.52 ppm). High-Resolution Mass Spectra were 
obtained at the Korea Basic Science Institute (Daegu, South Korea) 
on a Jeol JMS 700 high resolution mass spectrometer. 1a, 1u, 1y, 
and 3a are commercially available compounds. 
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2. Immobilization of Co/Rh Nanoparticles on Charcoal 15 
  To a two-neck flask were added o-dichlorobenzene (10 mL), 
oleic acid (0.2 mL), and trioctylphosphine oxide (0.4 g). While the 
solution was heated at 180 oC, a solution of metal carbonyl 
Co2Rh2(CO)12 (0.8 g) in 25 ml o-dichlorobenzene was injected into 
the flask. The resulting solution was heated to 180 oC for 2 h and 
then concentrated to a volume of 5 mL. The concentrated solution 
was cooled to room temperature. To the cooled solution was added 
30 mL of THF. After the solution was well stirred for 10 min, 
flame-dried charcoal (1.6 g) was added to the solution. After the 
resulting solution had been refluxed for 12 h, the precipitates were 
filtered and washed with diethyl ether (20 mL), dichloromethane (20 
mL), acetone (20 mL), and methanol (20 mL). Vacuum drying gave 
a black solid.  
3. Experimental Procedures 
A. General procedure 1: Synthesis of indoles catalyzed by Co2Rh2/C 
 
  Reactions were performed in a tube-type schlenk flask equipped 
with a stirring bar and capped with a rubber septum. The followings 
were placed in the flask in order: a substrate (0.25 mmol), 5 mol% 
of Co2Rh2 (90 mg of the immobilized Co2Rh2/C)
16, and methanol (3 
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mL). The solution was bubbled by hydrogen gas for 1 hour. The 
solution was stirred for 24 h and then was filtered and concentrated 
by a rotary evaporator. The product was purified by chromatography 
on a silica gel column eluting with either hexane/ethyl acetate (10:1) 
or pentane/ether (5:1) according to the compounds’ Rf values. 
Products were characterized by 1H NMR, 13C NMR, 19F NMR, and 
HRMS. Isolated yields: 49 to 97% depending on substrates and 
conditions.  
B. General Procedure 2: Vicarious nucleophilic aromatic substitution17 
(1k, 1l, 1t, 1v, and 1α) 
 
A solution of 10 mmol of an aromatic nitro compound and 1.2 equiv 
of 4-chlorophenoxyacetonitrile in anhydrous DMF (10 mL) was 
added dropwise to a solution of 2.3 equivalents of potassium tert-
butoxide in DMF (15 mL) at -24 oC. The color of the reaction 
mixture was turned to deep purple very soon, and the mixture was 
stirred at -24 oC for 2.5 h. After reaction, the reaction mixture was 
transferred into 200 mL of ice cold 5 % HCl. The solution was 
directly extracted with ethyl acetate and the extracts were purified 
by flash chromatography on a silica gel column eluting with 
24 
 
petroleum ether/ethyl acetate (15:1). Isolated yields: 55 to 61% 
depending on reactants and conditions. 
C. General Procedure 3: Nucleophilic aromatic substitution18 (1e, 1f, 
1g, 1h, and 1z) 
 
  To a one-neck schlenk were added 1-fluoro-2-nitrobenzene (5 
mmol), 1 equiv of phenylacetonitrile, 1 equiv of tetrabutyl-
ammonium hydrogensulfate (TBAHS) and 50% aqueous NaOH 
solution (2 mL) with distilled toluene (15 mL). The reaction mixture 
was reacted under the specified temperature and time. The mixture 
was poured into 3 M HCl. The mixture was then stirred at 20 oC for 
30 min and then the organic layer was separated with diethyl ether. 
The ether solution was dried over anhydrous MgSO4, filtered and 
concentrated in vacuo, and the residue was purified by flash column 
chromatography on a silica gel column eluting with hexane/ethyl 
acetate (25:1). Isolated yields: 52 to 68% depending on reactants 
and conditions. 




  To 1 equiv of ethyl cyanoacetate in 10 mL of anhydrous DMSO was 
added 1 equiv of sodium hydride in 5 mL of anhydrous DMSO. After 
the solution was stirred for 10 min, 1,4-dichloro-2-nitrobenzene 
or 1,4-dibromo-2-nitrobenzene (10 mmol) was added. The 
reaction mixture was stirred at room temperature for 1 h. After the 
solution was quenched with water, the organic layer was extracted 
with dichloromethane. The CH2Cl2 solution was dried over 
anhydrous MgSO4, filtered and concentrated in vacuo, and the 
residue was purified by flash column chromatography on a silica gel 
column eluting with petroleum ether/ethyl acetate (10:1). Isolated 
yields: 71 to 73% depending on reactants and conditions. 
E. General procedure 5 (1o) 
 
  To 5 mmol of ester in DMSO was added brine (prepared by 
dissolving 1.5 equivalent of NaCl in water). The reaction mixture 
was stirred at 110 oC for 18 h. The mixture was allowed to cool 
down to 20 oC, then was diluted with ethyl acetate. The organic 
solution was dried over anhydrous MgSO4, filtered and concentrated 
in vacuo, and the residue was purified by flash column 
26 
 
chromatography on a silica gel column eluting with petroleum 
ether/ethyl acetate (2:1). Isolated yields: 99% 
F. General procedure 6: Direct alkylation 20, 21 (1b, 1c, 1d, 1i, 1m, 1n, 
1q, 1r, 1w, 1x, 3b, 3c, and 3d) 
 
  A 10 mmol of substrate was dissolved in a proper solvent as shown 
above. 1.1 equiv of potassium carbonate was added to the solution 
and the resulting solution was stirred for 20 min. 1.1 Equiv of a 
corresponding alkyl halide was slowly added. After the solution was 
stirred for a few hours, the resulting solution was quenched with 
water and the organic layer was extracted with dichloromethane. 
The organic solution was dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo, and the residue was purified by flash column 
chromatography on a silica gel column eluting with petroleum 
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ether/ethyl acetate (20:1). Isolated yields: 51 to 99% depending on 
reactants and conditions. 
G. General procedure 722 (1j) 
  To a stirred solution of benzaldehyde (10 mmol) and sodium 
cyanide (10 mmol) in water (20 mL) at 0°C was added sodium 
bisulfite (10 mmol). The reaction mixture was stirred at room 
temperature for 6 h. The product was extracted with benzene and 
the extracts were washed successively with H2O and brine, dried 
over anhydrous MgSO4, filtered, and concentrated in vacuo to afford 
2-hydroxy-2-phenylacetonitrile. Without purification, a solution of 
2-hydroxy-2-phenylacetonitrile (7 mmol) was added to a stirred 
solution of pyridine (14 mmol) and phosphorus oxychloride (8.4 
mmol) in anhydrous benzene (20 mL) at room temperature. The 
reaction mixture was stirred at the same temperature for overnight 
and the solvent was evaporated in vacuo. The residue was diluted 
with diethyl ether and water. Removal of the solvent, followed by 
chromatography eluting with hexane/ethyl acetate (20:1) gave a 








4. Characterization Data for Isolated Products 
 
2-(5-Bromo-2-nitrophenyl)acetonitrile (Table 1) 
Yellow solid (1.37g, 57%); m. p. 106.7 oC; 1H NMR (400 MHz, 
DMSO-d6) δ 8.09 (d, J = 8.7 Hz, 1 H), 7.96 (s, 1 H), 7.88 (d, J = 
8.7 Hz, 1 H), 4.32 (s, 2 H); 13C NMR (100 MHz, DMSO-d6) δ 
146.85, 134.46, 132.67, 128.73, 128.03, 127.43, 117.45, 40.15, 
39.94, 39.73, 39.52, 39.31, 39.10, 38.89, 21.39; HRMS (EI+): m/z 
calcd for [C8H5BrN2O2]
+: 239.9534, found 239.9535.  
 
2-(2-Nitrophenyl)propanenitrile (Table 2, Entry 2, 1b)  
Yellow solid (1.72g, 98%); m. p. 43.3 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.02 (d, J = 8.1 Hz, 1 H), 7.78 (d, J = 7.8 Hz, 1 H), 7.69 (t, J = 
7.5 Hz, 1 H), 7.50 (t, J = 7.7 Hz, 1 H), 4.79-4.61 (m, 1 H), 1.69 (d, 
J = 7.1 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 223.91, 147.47, 
134.37, 132.30, 129.69, 129.41, 125.61, 120.76, 77.42, 77.16, 
76.91, 28.10, 21.21; HRMS (EI+): m/z calcd for [C9H8N2O2]
+: 
177.0664, found 177.0662.  
 
2-(2-Nitrophenyl)butanenitrile (Table 2, Entry 3, 1c)  
Yellow liquid (1.80g, 95%); 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J 
= 8.1 Hz, 1 H), 7.75-7.61 (m, 2 H), 7.48 (t, J = 7.6 Hz, 1 H), 4.59 
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(dd, J = 8.7, 4.9 Hz, 1 H), 2.09-1.78 (m, 2 H), 1.11 (t, J = 7.3 Hz, 
3 H); 13C NMR (125 MHz, CDCl3) δ 147.44, 133.86, 130.79, 129.89, 
129.12, 125.34, 119.69, 35.02, 28.61, 11.53; HRMS (EI+): m/z calcd 
for [C10H10N2O2]
+: 191.0821, found 191.0824.  
 
2-(2-Nitrophenyl)pentanenitrile (Table 2, Entry 4, 1d)  
Yellow liquid (1.98g, 97%); 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J 
= 8.2 Hz, 1 H), 7.73 (d, J = 7.7 Hz, 1 H), 7.66 (t, J = 7.6 Hz, 1 H), 
7.48 (t, J = 7.7 Hz, 1 H), 4.81-4.53 (m, 1 H), 1.99-1.74 (m, 3 H), 
1.70-1.46 (m, J = 15.0, 7.4 Hz, 3H), 0.95 (t, J = 7.3 Hz, 4H); 13C 
NMR (125 MHz, CDCl3) δ 147.33, 133.87, 131.08, 129.84, 129.03, 
125.27, 119.77, 37.04, 33.26, 20.39, 12.94; HRMS (EI+): m/z calcd 
for [C11H12N2O2]
+: 205.0977, found 205.0979.  
 
2-(2-Nitrophenyl)-2-phenylacetronitrile (Table 2, Entry 5, 1e)  
Yellow oil (0.75g, 63%); 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 
8.0 Hz, 1 H), 7.63-7.52 (m, 2 H), 7.45-7.37 (m, 1 H), 7.30-7.16 
(m, 5 H), 6.04 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 147.65, 
134.20, 134.11, 130.96, 130.48, 129.75, 129.32, 128.70, 127.89, 
125.77, 118.68, 77.48, 77.16, 76.84, 38.33; HRMS (EI+): m/z calcd 
for [C14H10N2O2]




2-(4-fluorophenyl)-2-(2-nitrophenyl)acetonitrile (Table 2, Entry 
6, 1f) 
Yellow oil (0.79g, 62%); 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 
8.1 Hz, 1 H), 7.62 (qd, J = 7.8, 1.3 Hz, 2 H), 7.48-7.43 (m, 1 H), 
7.24-7.17 (m, 2 H), 6.97-6.90 (m, 2 H), 6.04 (s, 1 H); 13C NMR 
(125 MHz, CDCl3) δ 163.63, 161.65, 147.60, 134.33, 130.85, 
130.30, 130.06, 130.04, 129.94, 129.82, 129.75, 125.92, 118.55, 
116.44, 116.26, 77.42, 77.16, 76.91, 37.78; 19F NMR (376 MHz, 
CDCl3) δ -112.51, -112.52, -112.53, -112.55, -112.56, -112.57, 
-112.58; HRMS (EI+): m/z calcd for [C14H9FN2O2]
+: 257.0726, 
found 257.0729.  
 
2-(4-Chlorophenyl)-2-(2-nitrophenyl)acetonitrile (Table 2, 
Entry 7, 1g) 
Yellow oil (0.70g, 52%); 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 
8.2 Hz, 1 H), 7.57-7.48 (m, 2 H), 7.39-7.32 (m, 1 H), 7.16-7.07 
(m, 4 H), 5.96 (s, 1 H); 13C NMR (125 MHz, CDCl3) δ 147.29, 
134.41, 134.21, 132.63, 130.74, 129.81, 129.70, 129.21, 129.12, 
125.70, 118.21, 77.42, 77.16, 76.90, 37.75; HRMS (EI+): m/z calcd 
for [C14H9ClN2O2]
+: 273.0431, found 273.0428.  
 
 
2-(4-Methoxyphenyl)-2-(2-nitrophenyl)acetonitrile (Table 2, 
Entry 8, 1h) 
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Yellow oil (0.91g, 68%); 1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 
8.1 Hz, 1 H), 7.66 (d, J = 7.8 Hz, 1 H), 7.61 (t, J = 7.6 Hz, 1 H), 
7.45 (t, J = 7.7 Hz, 1 H), 7.14 (d, J = 8.6 Hz, 2 H), 6.79 (d, J = 8.4 
Hz, 2 H), 6.02 (s, 1 H), 3.70 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
159.85, 147.75, 134.21, 131.04, 130.85, 129.69, 129.25, 126.13, 
125.88, 118.97, 114.79, 77.48, 77.16, 76.84, 55.44, 37.77; HRMS 
(EI+): m/z calcd for [C15H12N2O3]
+: 269.0926, found 269.0928 
 
2-(2-Nitrophenyl)-3-phenylpropanenitrile (Table 2, Entry 9, 1i) 
White solid (2.24g, 89%); m. p. 94.9 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.01 (m, 1 H), 7.63 (s, 2 H), 7.48 (m, 1 H), 7.23 (m, 5 H), 4.94-
4.85 (m, 1 H), 3.25 (d, J = 13.4 Hz, 1 H), 3.03 (m, 1 H); 13C NMR 
(100 MHz, CDCl3) δ 147.63, 135.68, 134.22, 130.64, 129.62, 
129.43, 128.91, 127.84, 125.78, 119.65, 77.48, 77.16, 76.84, 41.51, 
36.60; HRMS (EI+): m/z calcd for [C15H12N2O2]
+: 253.0977, found 
253.0975.  
 
2-Chloro-2-(2-nitrophenyl)acetonitrile (Table 2, Entry 10, 1j) 
White solid (1.21g, 62%); m. p. 52.9 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.10 (d, J = 7.8 Hz, 1 H), 7.97 (d, J = 7.9 Hz, 1 H), 7.75 (t, J = 
7.8 Hz, 1 H), 7.62 (t, J = 7.8 Hz, 1 H), 6.52 (s, 1 H); 13C NMR (125 
MHz, CDCl3) δ 146.57, 134.87, 131.82, 130.54, 128.10, 126.17, 
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115.34, 77.41, 77.16, 76.91, 40.36; HRMS (EI+): m/z calcd for 
[C8H5ClN2O2]
+: 196.0040, found 196.0037.  
 
2-(5-Fluoro-2-nitrophenyl)acetonitrile (Table 2, Entry 11, 1k) 
Yellow solid (0.99g, 55%); m. p. 71.1 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.25-8.17 (m, 1 H), 7.44-7.36 (m, 1 H), 7.22-7.13 (m, 1 H), 
4.18 (s, 2 H), 4.18 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 166.63, 
164.04, 143.67, 129.48, 129.39, 129.04, 128.94, 128.90, 118.61, 
118.35, 116.84, 116.61, 115.93, 77.48, 77.16, 76.84, 23.12; 19F 
NMR (376 MHz, cdcl3) δ -100.29, -100.31, -100.33, -100.34; 
HRMS (EI+): m/z calcd for [C8H5FN2O2]
+: 180.0335, found 
180.0337.  
 
2-(5-Chloro-2-nitrophenyl)acetonitrile (Table 2, Entry 12, 1l) 
Yellow solid (1.21g, 62%); m. p. 92.9 oC; 1H NMR (500 MHz, 
DMSO-d6) δ 8.21 (d, J = 8.8 Hz, 1 H), 7.84 (d, J = 2.1 Hz, 1 H), 
7.76 (dd, J = 8.8, 2.2 Hz, 1 H), 4.35 (s, 2 H); 13C NMR (125 MHz, 
DMSO-d6) δ 146.39, 138.97, 131.53, 129.63, 128.75, 127.46, 
117.39, 40.02, 39.85, 39.69, 39.52, 39.35, 39.19, 39.02, 21.51; 






2-(5-Chloro-2-nitrophenyl)propanenitrile (Table 2, Entry 13, 
1m)  
White solid (1.91g, 91%); m. p. 95.7 oC; 1H NMR (400 MHz, CDCl3) 
δ 7.97 (d, J = 8.8 Hz, 1 H), 7.71 (d, J = 1.4 Hz, 1 H), 7.43 (dd, J = 
8.8, 1.4 Hz, 1 H), 4.72 (q, J = 7.1 Hz, 1 H), 1.66 (d, J = 7.1 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 145.68, 141.13, 134.40, 129.93, 
129.73, 127.33, 120.23, 77.48, 77.16, 76.84, 28.19, 21.17; HRMS 
(EI+): m/z calcd for [C9H7ClN2O2]
+: 210.0196, found 210.0198.  
 
2-(5-Chloro-2-nitrophenyl)pentanenitrile (Table 2, Entry 14, 1n)  
Yellow oil (2.07g, 87%); 1H NMR (400 MHz, cdcl3) δ 7.96 (d, J = 
8.8 Hz, 1 H), 7.69 (d, J = 2.0 Hz, 1 H), 7.42 (dd, J = 8.8, 2.0 Hz, 1 
H), 4.67 (dd, J = 8.4, 6.0 Hz, 1 H), 1.92-1.72 (m, 2 H), 1.68-1.42 
(m, 2 H), 0.94 (t, J = 7.3 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
145.72, 140.88, 133.55, 130.26, 129.56, 127.29, 119.52, 77.48, 
77.16, 76.84, 37.42, 33.68, 20.79, 13.28; HRMS (EI+): m/z calcd for 
[C11H11ClN2O2]
+: 239.0587, found 239.0589.  
 
2-(4-Chloro-2-nitrophenyl)acetonitrile (Table 2, Entry 15, 1o) 
Yellow solid (0.97g, 99%); m. p. 86.7 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.11 (s, 1 H), 7.63 (s, 2 H), 4.11 (s, 2 H); 13C NMR (100 MHz, 
CDCl3) δ 147.87, 135.75, 134.56, 132.35, 126.09, 124.31, 116.05, 
34 
 
77.48, 77.16, 76.84, 22.49; HRMS (EI+): m/z calcd for 
[C8H5ClN2O2]
+: 196.0040, found 196.0038.  
 
Ethyl 2-(4-chloro-2-nitrophenyl)-2-cyanoacetate (Table 2, 
Entry 16, 1p)  
Yellow oil (1.90g, 71%); 1H NMR (500 MHz, CDCl3) δ 8.20-8.02 
(m, 1 H), 7.72-7.55 (m, 2 H), 5.61-5.43 (m, 1 H), 4.34-4.10 (m, 2 
H), 1.34-1.16 (m, 3 H); 13C NMR (125 MHz, CDCl3) δ 163.18, 
147.66, 136.63, 134.44, 132.63, 126.22, 123.76, 114.12, 77.36, 
77.11, 76.85, 64.07, 40.86, 13.83; HRMS (EI+): m/z calcd for 
[C11H9ClN2O4]
+: 197.1204, found 197.1205; HRMS (EI+): m/z calcd 
for [C18H17NO]
+: 269.0329, found 2690331; IR (neat): 1751cm-1.  
 
2-(5-Bromo-2-nitrophenyl)propanenitrile (Table 2, Entry 17, 1q) 
Yellow solid (2.42g, 95%); m. p. 94.7 oC; 1H NMR (500 MHz, 
DMSO-d6) δ 8.02 (d, J = 8.7 Hz, 2 H), 7.87 (d, J = 8.7 Hz, 1 H), 
4.75 (q, J = 7.1 Hz, 1 H), 1.67 (d, J = 7.1 Hz, 3 H); 13C NMR (125 
MHz, DMSO-d6) δ 146.85, 133.96, 132.58, 132.41, 127.90, 127.27, 
120.87, 40.02, 39.86, 39.69, 39.52, 39.35, 39.19, 39.02, 27.14, 
19.30; HRMS (EI+): m/z calcd for [C9H7BrN2O2]
+: 253.9691, found 
253.9693.  
 
2-(5-Bromo-2-nitrophenyl)pantanenitrile (Table 2, Entry 18, 1r)  
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Yellow solid (2.60g, 92%); m. p. 54.6 oC; 1H NMR (500 MHz, 
DMSO-d6) δ 8.08-7.93 (m, 2 H), 7.87 (d, J = 8.7 Hz, 1 H), 4.67 
(dd, J = 9.9, 5.1 Hz, 1 H), 2.09-1.82 (m, 2 H), 1.59-1.38 (m, 2 H), 
0.95 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6) δ 146.91, 
133.00, 132.76, 132.59, 127.78, 127.38, 120.03, 40.02, 39.86, 
39.69, 39.52, 39.35, 39.19, 39.02, 35.31, 32.69, 20.24, 13.05; 
HRMS (EI+): m/z calcd for [C11H11BrN2O2]
+: 282.0004, found 
282.0002.  
 
Ethyl 2-(4-bromo-2-nitrophenyl)-2-cyanoacetate (Table 2, 
Entry 19, 1s)  
Red solid (2.28g, 73%); m. p. 66.8 oC; 1H NMR (500 MHz, CDCl3) δ 
8.30-8.22 (m, 1 H), 7.81 (d, J = 8.3 Hz, 1 H), 7.58 (d, J = 8.3 Hz, 
1 H), 5.55 (s, 1 H), 4.23 (q, J = 7.1 Hz, 2 H), 1.25 (t, J = 7.1 Hz, 3 
H); 13C NMR (125 MHz, CDCl3) δ 163.17, 147.80, 137.53, 132.78, 
129.20, 124.30, 124.28, 114.14, 77.41, 77.16, 76.90, 64.24, 41.02, 
13.98; HRMS (EI+): m/z calcd for [C11H9BrN2O4]
+: 312.9824, found 
312.9820; IR (neat): 1750cm-1.  
 
2-(2-Nitro-5-(trifluoromethyl)phenyl)acetonitrile (Table 2, Entry 
20, 1t)  
Yellow solid (1.35g, 59%); m. p. 57.7 oC; 1H NMR (400 MHz, CDCl3) 
δ δ 8.25-8.15 (m, J = 8.2, 4.4 Hz, 1H), 7.90 (s, 1H), 7.83-7.72 




NMR (125 MHz, CDCl3) δ 149.65, 136.36, 136.09, 135.82, 135.55, 
128.60, 128.57, 127.06, 127.03, 126.98, 126.59, 123.64, 121.47, 
115.62, 77.41, 77.16, 76.91, 22.69; 19F NMR (376 MHz, CDCl3) δ -
63.32; HRMS (EI+): m/z calcd for [C9H5F3N2O2]
+: 179.1310, found 
179.1313.  
 
2-(5-Methoxy-2-nitrophenyl)acetonitrile (Table 2, Entry 22, 1v)  
Yellow solid (1.17g, 61%); m. p. 81.2 oC; 1H NMR (500 MHz, 
DMSO-d6) δ 8.22 (d, J = 9.1 Hz, 1 H), 7.25 (d, J = 2.4 Hz, 1 H), 
7.17 (dd, J = 9.1, 2.6 Hz, 1 H), 4.33 (s, 2 H), 3.92 (s, 3 H); 13C 
NMR (125 MHz, DMSO-d6) δ 163.48, 140.43, 129.45, 128.31, 
117.75, 117.30, 114.06, 56.31, 40.02, 39.86, 39.69, 39.52, 39.35, 
39.19, 39.02, 22.31; HRMS (EI+): m/z calcd for [C9H8N2O3]
+: 
193.0613, found 193.0616.  
 
2-(5-Methoxy-2-nitrophenyl)propanenitrile (Table 2, Entry 23, 
1w)  
Yellow oil (1.91g, 93%); 1H NMR (400 MHz, CDCl3) δ 8.08 (d, J = 
9.2 Hz, 1 H), 7.16 (d, J = 2.6 Hz, 1 H), 6.88 (dd, J = 9.2, 2.6 Hz, 
1H), 4.85 (q, J = 7.0 Hz, 1 H), 3.87 (s, 3 H), 1.63 (d, J = 7.1 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 224.07, 164.08, 140.08, 135.45, 
128.71, 120.92, 114.93, 113.77, 77.48, 77.16, 76.84, 56.21, 28.63, 
21.12; HRMS (EI+): m/z calcd for [C10H10N2O3]





2-(5-Methoxy-2-nitrophenyl)pentanenitrile (Table 2, Entry 24, 
1x)  
Yellow solid (2.13g, 91%); m p. 63.7 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.08 (d, J = 9.2 Hz, 1 H), 7.14 (d, J = 2.6 Hz, 1 H), 6.87 (dd, J = 
9.2, 2.6 Hz, 1 H), 4.83 (dd, J = 9.4, 4.8 Hz, 1 H), 3.87 (s, 3 H), 
1.94-1.69 (m, 2 H), 1.66-1.45 (m, 2 H), 0.93 (t, J = 7.3 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 163.96, 140.21, 134.68, 128.76, 
120.26, 115.34, 113.83, 77.48, 77.16, 76.84, 56.25, 37.48, 34.26, 
20.85, 13.36; HRMS (EI+): m/z calcd for [C18H23N]
+: 235.1083, 
found 235.1081.  
 
2,2-Bis(2-nitrophenyl)acetonitrile (Table 2, Entry 26, 1z) 
Yellow solid (0.81g, 58%); m. p. 118 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.14-8.09 (m, 2 H), 7.64 (m, 2 H), 7.56-7.49 (m, 4 H), 6.80 (s, 
1 H); 13C NMR (125 MHz, CDCl3) δ 147.64, 134.47, 130.71, 
130.37, 129.53, 126.42, 117.34, 77.41, 77.16, 76.91, 36.61; HRMS 
(EI+): m/z calcd for [C14H9N3O4]
+: 284.0671, found 284.0675.  
 
2-(1-Nitronaphthalen-2-yl)acetonitrile (Table 2, Entry 27, 1α)  
Yellow solid (1.29g, 61%); m. p. 120.2 oC;  1H NMR (400 MHz, 
DMSO-d6) δ 8.35 (d, J = 8.5 Hz, 1 H), 8.19 (d, J = 7.7 Hz, 1 H), 
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7.86-7.70 (m, 4 H), 4.36 (s, 2 H); 13C NMR (100 MHz, DMSO-d6) 
δ 146.45, 132.89, 132.42, 129.75, 128.47, 128.11, 126.47, 123.68, 
121.71, 121.14, 117.41, 40.15, 39.94, 39.73, 39.52, 39.31, 39.10, 
38.89, 19.95; HRMS (EI+): m/z calcd for [C12H8N2O2]
+: 212.0586, 
found 212.0589.   
 
2-(6-Methoxy-3-nitropyridin-2-yl)propanenitrile (Table 3, 
Entry 2, 3b) 
White solid (2.05g, 99%); m. p. 60.9 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.26 (d, J = 9.0 Hz, 1 H), 6.76 (d, J = 9.0 Hz, 1 H), 4.91 (d, J = 
7.1 Hz, 1 H), 4.03 (s, 3 H), 1.67 (d, J = 7.1 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 165.46, 150.86, 138.03, 136.67, 119.58, 111.59, 
77.42, 77.16, 76.90, 55.08, 31.83, 18.69; HRMS (EI+): m/z calcd for 
[C9H9N3O3]
+: 208.0722, found 208.0724.  
 
2-(6-Methoxy-3-nitropyridin-2-yl)pentanenitrile (Table 3, 
Entry 3, 3c)  
Yellow liquid (1.34g, 57%); 1H NMR (500 MHz, CDCl3) δ 8.23 (d, J 
= 9.1 Hz, 1 H), 6.74 (d, J = 9.0 Hz, 1 H), 4.83 (dd, J = 9.2, 5.3 Hz, 
1 H), 3.99 (s, 3 H), 2.00-1.82 (m, 2 H), 1.63-1.41 (m, 2 H), 0.90 
(t, J = 7.4 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 165.07, 150.17, 
138.04, 136.50, 118.53, 111.20, 54.80, 36.97, 34.92, 20.28, 12.99; 
HRMS (EI+): m/z calcd for [C11H13N3O3]






(Table 3, Entry 4, 3d)   
White solid (1.42g, 51%); m. p. 81.3oC; 1H NMR (500 MHz, CDCl3) 
δ 8.27 (d, J = 7.7 Hz, 1 H), 6.78 (d, J = 7.7 Hz, 1 H), 5.32-5.10 
(m, 1 H), 4.04 (s, 2 H), 3.97 (s, 3 H), 3.29-3.18 (m, 1H), 3.05-
2.92 (m, 1 H), 1.20-1.00 (m, 3 H).; 13C NMR (125 MHz, CDCl3) δ 
168.95, 165.25, 147.81, 138.83, 136.71, 117.57, 111.85, 61.23, 
54.90, 35.68, 32.45, 13.84; HRMS (EI+): m/z calcd for 
[C12H13N3O5]
+: 280.0933, found 280.0932; IR (neat): 1735cm-1.  
 
5-Bromo-1H-indole (Table 1) 
Brown solid (33.33mg, 68%); m. p. 37 oC; 1H NMR (400 MHz, 
CDCl3) δ 8.09 (s, 1H), 7.69 (s, 1H), 7.21-7.16 (m, 2H), 7.12 (s, 
1H), 6.42 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 134.51, 129.75, 
125.49, 124.97, 123.36, 113.15, 112.55, 102.46, 77.48, 77.16, 
76.84; HRMS (EI+): m/z calcd for [C8H6BrN]
+: 194.9684, found 
194.9683.  
 
1H-Indole (Table 2, Entry 1, 2a) 
White solid (19.92mg, 68%); m. p. 51 oC; 1H NMR (500 MHz, CDCl3) 
δ 7.73 (s, 1 H), 7.55 (d, J = 7.7 Hz, 1 H), 7.18 (d, J = 7.8 Hz, 1 H), 
7.12-7.06 (m, 1 H), 7.02 (t, J = 7.3 Hz, 1 H), 6.95 (s, 1 H), 6.43 
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(s, 1 H); 13C NMR (125 MHz, CDCl3) δ 135.81, 127.88, 124.31, 
122.02, 120.79, 119.88, 111.17, 102.53, 77.42, 77.16, 76.91; HRMS 
(EI+): m/z calcd for [C8H7N]
+: 117.0578, found 117.0579.  
 
3-Methyl-1H-Indole (Table 2, Entry 2, 2b) 
Yellow solid (26.23mg, 80%); m. p. 97 oC; 1H NMR (400 MHz, 
CDCl3) δ 7.70 (s, 1 H), 7.51 (d, J = 7.8 Hz, 1 H), 7.23 (d, J = 8.0 
Hz, 1 H), 7.13-7.08 (m, 1 H), 7.04 (t, J = 8.0 Hz, 1 H), 6.85 (s, 1 
H), 2.26 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 136.35, 128.38, 
121.97, 121.69, 119.22, 118.94, 111.80, 111.06, 77.48, 77.16, 
76.84, 9.79; HRMS (EI+): m/z calcd for [C9H9N]
+: 131.0735, found 
131.0734.  
 
3-Ethyl-1H-Indole (Table 2, Entry 3, 2c) 
Yellow solid (28.17mg, 97%); m. p. 36 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.75 (s, 1 H), 7.53 (d, J = 7.9 Hz, 1 H), 7.24 (d, J = 8.1 
Hz, 1 H), 7.10 (t, J = 7.5 Hz, 1 H), 7.03 (t, J = 7.4 Hz, 1 H), 6.86 
(s, 1 H), 2.71 (q, J = 7.5 Hz, 2 H), 1.25 (t, J = 7.5 Hz, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 136.53, 127.55, 121.99, 120.55, 119.17, 
119.06, 118.93, 111.15, 77.41, 77.16, 76.91, 18.47, 14.59; HRMS 
(EI+): m/z calcd for [C10H11N]
+: 145.0891, found 145.0892.  
 
3-Propyl-1H -Indole (Table 2, Entry 4, 2d) 
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Brown oil (32.24mg, 81%); 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1 
H), 7.53 (d, J = 7.8 Hz, 1 H), 7.22 (d, J = 8.1 Hz, 1 H), 7.12-7.07 
(m, 1 H), 7.02 (m, 1 H), 6.83 (s, 1 H), 2.65 (t, J = 7.5 Hz, 2 H), 
1.70-1.60 (m, 2 H), 0.91 (t, J = 7.3 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 136.44, 127.76, 121.90, 121.24, 119.14, 117.04, 111.14, 
77.48, 77.16, 76.84, 27.41, 23.46, 14.32; HRMS (EI+): m/z calcd for 
[C11H13N]
+: 159.1048, found 159.1046.  
 
3-Phenyl-1H-indole (Table 2, Entry 5, 2e) 
Yellow solid (40.10mg, 83%); m. p. 86 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.01 (s, 1 H), 7.86 (d, J = 7.9 Hz, 1 H), 7.58 (d, J = 7.2 
Hz, 2 H), 7.36 (m, 2 H), 7.29 (d, J = 8.1 Hz, 1 H), 7.21 (s, 2 H), 
7.16 (m, 1 H), 7.11 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 136.76, 
135.67, 128.90, 127.60, 126.11, 125.84, 122.52, 121.92, 120.44, 
119.93, 118.40, 111.54, 77.41, 77.16, 76.91; HRMS (EI+): m/z calcd 
for [C14H11N]
+: 193.0891, found 193.0893.  
 
3-(4-Fluorophenyl)-1H-indole (Table 2, Entry 6, 2f) 
Brown solid (45.42mg, 86%); m. p. 94 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.06 (s, 1 H), 7.78 (d, J = 7.9 Hz, 1 H), 7.50 (m, 2 H), 
7.29 (d, J = 8.1 Hz, 1 H), 7.15 (m, 2H), 7.11 (d, J = 7.6 Hz, 1 H), 
7.03 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 162.58, 160.63, 
136.69, 131.66, 129.07, 129.01, 125.82, 122.63, 121.72, 120.52, 
119.64, 117.53, 115.80, 115.63, 111.58, 77.41, 77.16, 76.91; 19F 
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NMR (376 MHz, CDCl3) δ -116.99; HRMS (EI
+): m/z calcd for 
[C14H10FN]
+: 211.0797, found 211.0795.  
 
3-(4-Chlorophenyl)-1H-indole (Table 2, Entry 7, 2g) 
Brown solid (40.41mg, 71%); m. p. 134 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.13 (s, 1 H), 7.80 (d, J = 7.9 Hz, 1 H), 7.51 (d, J = 8.4 
Hz, 2 H), 7.33 (m, 3 H), 7.24 (m, 1 H), 7.18 (m, 1 H), 7.12 (m, 1 
H); 13C NMR (125 MHz, CDCl3) δ 136.71, 134.14, 131.67, 129.00, 
128.69, 125.58, 122.70, 122.02, 120.64, 119.65, 117.22, 111.64, 
77.41, 77.16, 76.91; HRMS (EI+): m/z calcd for [C14H10ClN]
+: 
227.0502, found 227.0500.  
 
3-(4-Methoxyphenyl)-1H-indole (Table 2, Entry 8, 2h) 
Brown solid (43.54mg, 78%); m. p. 127 oC; 1H NMR (400 MHz, 
CDCl3) δ 8.05 (s, 1 H), 7.82 (d, J = 7.8 Hz, 1 H), 7.51 (d, J = 8.3 
Hz, 2 H), 7.31 (d, J = 8.0 Hz, 1 H), 7.16 (m, 2 H), 7.10 (m, 1H), 
6.92 (d, J = 8.3 Hz, 2 H), 3.77 (s, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 158.19, 136.68, 128.74, 128.23, 125.99, 122.42, 121.29, 120.26, 
119.85, 118.09, 114.38, 111.48, 77.48, 77.16, 76.84, 55.48; HRMS 
(EI+): m/z calcd for [C15H13NO]
+: 223.0997, found 223.0999. 
 
3-Benzyl-1H-indole (Table 2, Entry 9, 2i) 
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Brown solid (13.99mg, 27%; 25.39mg, 49% for 48 h); m. p. 104 oC; 
1H NMR (400 MHz, CDCl3) δ 7.80 (s, 1H), 7.44 (d, J = 7.1 Hz, 1H), 
7.25 (d, J = 6.5 Hz, 1H), 7.20 (s, 3H), 7.14 (s, 1H), 7.11 (d, J = 5.0 
Hz, 2H), 7.01 (d, J = 7.1 Hz, 1H), 6.80 (s, 1H), 4.03 (s, 2H); 13C 
NMR (100 MHz, CDCl3) δ 141.32, 136.55, 128.81, 128.45, 127.57, 
126.00, 122.45, 122.16, 119.48, 119.27, 115.94, 111.19, 77.48, 
77.16, 76.84, 31.72; HRMS (EI+): m/z calcd for [C15H13N]
+: 
207.1048, found 207.1049. 
 
1H-Indole (Table 2, Entry 10, 2j) 
White solid (16.38mg, 56%); m. p. 51 oC; 1H NMR (400 MHz, CDCl3) 
δ 7.54 (s, 1H), 7.12 (d, J = 7.9 Hz, 1H), 6.85 (d, J = 8.1 Hz, 1H), 
6.71-6.66 (m, 1H), 6.65 (s, 1H), 6.59 (t, J = 7.0 Hz, 1H), 6.03 (s, 
1H); 13C NMR (101 MHz, cdcl3) δ 135.88, 127.96, 124.24, 122.11, 
120.85, 119.93, 111.14, 102.74, 77.48, 77.16, 76.84; HRMS (EI+): 
m/z calcd for [C8H7N]
+: 117.0578, found 117.0579.  
 
5-Fluoro-1H-indole (Table 2, Entry 11, 2k) 
Brown solid (23.99mg, 71%); m. p. 42 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.02 (s, 1 H), 7.21 (m, 1 H), 7.19 (m, 1 H), 7.13 (m, 1 
H), 6.86 (m, 1 H), 6.44-6.40 (m, 1 H); 13C NMR (125 MHz, CDCl3) 
δ 159.02, 157.15, 132.43, 128.27, 126.03, 111.73, 111.66, 110.62, 
110.41, 105.63, 105.45, 102.92, 102.89, 77.41, 77.16, 76.91; 19F 
NMR (376 MHz, CDCl3) δ -124.95, -124.96, -124.97, -124.99, -
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125.00, -125.01; HRMS (EI+): m/z calcd for [C8H6FN]
+: 135.0484, 
found 135.0486.  
 
5-Chloro-1H-indole (Table 2, Entry 12, 2l) 
Brown solid (27.67mg, 73%); m. p. 65 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.18 (s, 1 H), 7.64 (s, 1 H), 7.32 (d, J = 8.6 Hz, 1 H), 
7.24 (m, 1 H), 7.18 (m, 1 H), 6.53 (s, 1 H); 13C NMR (125 MHz, 
CDCl3) δ 134.25, 129.07, 125.65, 125.58, 122.43, 120.23, 112.11, 
102.52, 77.41, 77.16, 76.91; HRMS (EI+): m/z calcd for [C8H6ClN]
+: 
151.0189, found 151.0188.  
 
5-Chloro-3-methyl-1H-indole (Table 2, Entry 13, 2m) 
Brown solid (31.47mg, 76%); m. p. 50 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.77 (s, 1 H), 7.45 (d, J = 1.7 Hz, 1 H), 7.13 (d, J = 8.6 
Hz, 1 H), 7.04 (dd, J = 8.6, 2.0 Hz, 1 H), 6.87 (s, 1 H), 2.20 (s, 3 
H); 13C NMR (125 MHz, CDCl3) δ 134.68, 129.54, 124.97, 123.14, 
122.21, 118.51, 112.05, 111.65, 77.41, 77.16, 76.90, 9.65; HRMS 
(EI+): m/z calcd for [C9H8ClN]
+: 165.0345, found 165.0343.  
 
5-Chloro-3-propyl-1H-indole (Table 2, Entry 14, 2n) 
Brown oil (43.09mg, 89%); 1H NMR (500 MHz, CDCl3) δ 7.79 (s, 1 
H), 7.48 (d, J = 1.5 Hz, 1 H), 7.14 (d, J = 8.6 Hz, 1 H), 7.03 (dd, J 
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= 8.6, 1.9 Hz, 1 H), 6.88 (s, 1 H), 2.59 (t, J = 7.5 Hz, 2 H), 1.66-
1.58 (m, 2 H), 0.90 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) 
δ 134.77, 128.92, 124.91, 122.68, 122.16, 118.67, 116.90, 112.11, 
77.41, 77.16, 76.91, 27.23, 23.39, 14.23; HRMS (EI+): m/z calcd for 
[C11H12ClN]
+: 193.0658, found 193.0659.  
 
6-Chloro-1H-indole (Table 2, Entry 15, 2o) 
Brown solid (26.91mg, 71%); m. p. 78 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.09 (s, 1 H), 7.56 (d, J = 8.4 Hz, 1 H), 7.37 (s, 1 H), 
7.20-7.16 (m, 1 H), 7.12 (d, J = 8.4 Hz, 1 H), 6.55 (s, 1 H); 13C 
NMR (125 MHz, CDCl3) δ 136.23, 127.96, 126.55, 124.97, 121.66, 
120.69, 111.08, 102.88, 77.41, 77.16, 76.90; HRMS (EI+): m/z calcd 
for [C8H6ClN]
+: 151.0189, found 151.0187.  
 
Ethyl 6-chloro-1H-indole-3-carboxylate (Table 2, Entry 16, 2p) 
White solid (50.88mg, 91%); m. p. 161oC; 1H NMR (400 MHz, 
CDCl3) δ 8.46 (s, 1H), 8.03 (d, J = 8.4 Hz, 1H), 7.84 (s, 1H), 7.35 
(s, 1H), 7.16 (s, 1H), 4.32 (q, J = 6.8 Hz, 2H), 1.35 (t, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 164.94, 136.54, 131.45, 129.32, 
124.56, 122.93, 122.73, 111.57, 109.62, 77.41, 77.16, 76.91, 60.14, 
14.69; HRMS (EI+): m/z calcd for [C11H10ClNO2]
+: 223.0400, found 




5-Bromo-3-methyl-1H-indole (Table 2, Entry 17, 2q) 
Brown solid (40.96mg, 78%); m. p. 76 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.77 (s, 1 H), 7.61 (s, 1 H), 7.17 (d, J = 8.5 Hz, 1 H), 
7.09 (d, J = 8.5 Hz, 1 H), 6.85 (s, 1 H), 2.19 (s, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 134.94, 130.21, 124.74, 122.97, 121.63, 
112.50, 111.57, 77.41, 77.16, 76.91, 9.65; HRMS (EI+): m/z calcd 
for [C9H8BrN]
+: 208.9840, found 208.9837.  
 
5-Bromo-3-propyl-1H-indole (Table 2, Entry 18, 2r) 
Brown oil (31.55mg, 53%); 1H NMR (500 MHz, CDCl3) δ 7.80 (s, 1 
H), 7.64 (s, 1 H), 7.16 (d, J = 8.6 Hz, 1 H), 7.10 (d, J = 8.6 Hz, 1 
H), 6.86 (s, 1 H), 2.58 (t, J = 7.5 Hz, 2 H), 1.66-1.57 (m, 2 H), 
0.90 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 135.04, 
129.59, 124.69, 122.50, 121.77, 119.16, 116.83, 112.57, 112.46, 
77.41, 77.16, 76.91, 27.22, 23.39, 14.23; HRMS (EI+): m/z calcd for 
[C11H12BrN]
+: 237.0153, found 237.0151.  
 
Ethyl 6-bromo-1H-indole-3-carboxylate (Table 2, Entry 19, 2s) 
White solid (61.66mg, 92%); m. p. 105oC; 1H NMR (400 MHz, 
CDCl3) δ 8.72 (s, 1 H), 7.97 (d, J = 8.5 Hz, 1 H), 7.81 (d, J = 2.6 
Hz, 1 H), 7.50 (s, 1 H), 7.30 (d, J = 8.5 Hz, 1 H), 4.32 (q, J = 7.1 
Hz, 2 H), 1.35 (t, J = 7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
165.11, 136.99, 131.52, 125.48, 124.85, 122.99, 116.85, 114.65, 
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109.46, 77.48, 77.16, 76.84, 60.20, 14.67; HRMS (EI+): m/z calcd 
for [C11H10BrNO2]
+: 266.9895, found 266.9892; IR (neat): 1666cm-
1.  
 
5-(Trifluoromethyl)-1H-indole (Table 2, Entry 20, 2t) 
Brown solid (22.68mg, 49%); m. p. 67 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.23 (s, 1 H), 7.86 (s, 1 H), 7.35 (m, 2 H), 7.20 (m, 1H), 
6.56-6.54 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 137.22, 127.34, 
125.97, 118.91, 118.88, 118.65, 118.62, 111.40, 103.73, 77.41, 
77.16, 76.91; 19F NMR (376 MHz, CDCl3) δ -60.27; HRMS (EI
+): 
m/z calcd for [C9H6F3N]
+: 185.0452, found 185.0451.  
 
6-(Trifluoromethyl)-1H-indole (Table 2, Entry 21, 2u) 
Reddish brown solid (33.79mg, 73%); m. p. 103 oC; 1H NMR (500 
MHz, CDCl3) δ 8.21 (s, 1 H), 7.63 (d, J = 8.3 Hz, 1 H), 7.56 (s, 1 
H), 7.27 (d, J = 8.3 Hz, 1 H), 7.23 (m, 1 H), 6.52 (s, 1 H); 13C NMR 
(125 MHz, CDCl3) δ 134.75, 130.34, 126.96, 121.23, 116.66, 
116.64, 108.74, 108.71, 103.10, 77.41, 77.16, 76.91; 19F NMR (376 
MHz, CDCl3) δ -60.54; HRMS (EI
+): m/z calcd for [C9H6F3N]
+: 
185.0452, found 185.0450.  
 
5-(Trifluoromethyl)-1H-indole (Table 2, Entry 22, 2v) 
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Brown oil (25.02mg, 68%); m. p. 51 oC; 1H NMR (500 MHz, CDCl3) 
δ 7.98 (s, 1 H), 7.18 (d, J = 8.8 Hz, 1 H), 7.08 (m, 1 H), 7.03 (d, J 
= 2.4 Hz, 1 H), 6.78 (dd, J = 8.8, 2.5 Hz, 1 H), 6.40 (s, 1 H), 3.77 
(s, 3 H); 13C NMR (125 MHz, CDCl3) δ 154.31, 131.09, 128.41, 
124.99, 112.46, 111.83, 102.49, 102.46, 77.41, 77.16, 76.91, 55.99; 
HRMS (EI+): m/z calcd for [C9H9NO]
+: 147.0684, found 147.0684.  
 
5-Methoxy-3-methyl-1H-indole (Table 2, Entry 23, 2w) 
Brown solid (36.27mg, 90%); m. p. 62 oC; 1H NMR (400 MHz, 
CDCl3) δ 7.67 (s, 1 H), 7.11 (d, J = 8.8 Hz, 1 H), 6.93 (s, 1 H), 
6.83 (s, 1 H), 6.77 (d, J = 8.7 Hz, 1 H), 3.79 (s, 3 H), 2.22 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 153.95, 131.54, 128.71, 122.62, 
112.15, 111.81, 111.47, 100.78, 77.48, 77.16, 76.84, 56.05, 9.84; 
HRMS (EI+): m/z calcd for [C10H11NO]
+: 161.0841, found 161.0838.  
 
5-Methoxy-3-propyl-1H-indole (Table 2, Entry 24, 2x) 
Brown oil (34.54mg, 73%); m. p. 50 oC; 1H NMR (500 MHz, CDCl3) 
δ 7.85 (s, 1 H), 7.26 (m, 1 H), 7.09 (s, 1 H), 6.97 (s, 1 H), 6.89 
(m, 1 H), 3.91 (s, 3 H), 2.73 (t, J = 7.6 Hz, 2 H), 1.81-1.72 (m, 2 
H), 1.04 (t, J = 7.4 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 153.87, 
131.66, 128.13, 122.15, 116.76, 112.02, 111.83, 101.11, 77.41, 
77.16, 76.91, 56.10, 27.44, 23.30, 14.32; HRMS (EI+): m/z calcd for 
[C12H15NO]




5,6-Dimethoxy-1H-indole (Table 2, Entry 25, 2y) 
Dark brown solid (26.14mg, 59%); m. p. 152 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.04 (s, 1 H), 7.01 (s, 1 H), 6.97 (s, 1 H), 6.76 (s, 1 H), 
6.36 (s, 1 H), 3.83 (s, 3 H), 3.79 (s, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 147.08, 145.18, 130.23, 122.87, 120.64, 102.39, 102.30, 
94.58, 77.41, 77.16, 76.91, 56.39, 56.23; HRMS (EI+): m/z calcd for 
[C10H11NO2]
+: 177.0790, found 177.0791.  
 
2-(1H-indol-3-yl)aniline (Table 2, Entry 26, 2z) 
Brown oil (41.13mg, 79%); 1H NMR (500 MHz, CDCl3) δ 8.16 (s, 1 
H), 7.53 (m, 1 H), 7.28 (m, 1 H), 7.22 (m, 1 H), 7.19-7.12 (m, 2 
H), 7.07 (m, 2 H), 6.74 (m, 2 H), 3.73 (s, 2 H); 13C NMR (125 MHz, 
CDCl3) δ 144.78, 136.27, 131.37, 128.06, 126.54, 123.11, 122.52, 
120.63, 120.35, 120.12, 118.50, 115.51, 114.77, 111.47, 77.41, 
77.16, 76.91; HRMS (EI+): m/z calcd for [C14H12N2]
+: 208.1000, 
found 208.0997.  
 
1H-benzo[g]indole (Table 2, Entry 27, 2α) 
Brown solid (32.19mg, 77%); m. p. 168 oC; 1H NMR (499 MHz, 
CDCl3) δ 8.65 (s, 1 H), 7.84 (d, J = 8.1 Hz, 1 H), 7.80 (d, J = 8.1 
Hz, 1 H), 7.64 (d, J = 8.6 Hz, 1 H), 7.43 (d, J = 8.8 Hz, 1 H), 7.40 
(d, J = 7.3 Hz, 1 H), 7.34 (m, 1 H), 7.09 (m, 1 H), 6.62-6.57 (m, 1 
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H); 13C NMR (125 MHz, CDCl3) δ 130.52, 129.00, 125.57, 123.98, 
123.92, 122.38, 121.86, 120.94, 120.84, 119.46, 104.37, 77.41, 
77.16, 76.91; HRMS (EI+): m/z calcd for [C12H9N]
+: 167.0735, 
found 167.0738.  
 
5-Methoxy-1H-pyrrolo[3,2-b]pyridine (Table 3, Entry 1, 4a) 
White solid (22.59mg, 61%); m. p. 99 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.59 (s, 1 H), 7.50 (d, J = 8.7 Hz, 1 H), 7.24 (m, 1 H), 6.54 (d, J 
= 8.7 Hz, 1 H), 6.51 (s, 1 H), 3.93 (s, 3 H); 13C NMR (126 MHz, 
CDCl3) δ 160.39, 142.81, 126.70, 124.51, 122.09, 105.87, 102.68, 
77.42, 77.16, 76.91, 53.54; HRMS (EI+): m/z calcd for [C9H10N2O]
+: 
148.0637, found 148.0634.  
 
5-methoxy-3-methyl-1H-pyrrolo[3,2-b]pyridine (Table 3, 
Entry 2, 4b) 
White solid (29.19mg, 72%); m. p. 88 oC; 1H NMR (400 MHz, CDCl3) 
δ 8.19 (s, 1 H), 7.36 (d, J = 8.6 Hz, 1 H), 6.97 (s, 1 H), 6.48 (d, J 
= 8.6 Hz, 1 H), 3.92 (s, 3 H), 2.24 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 159.86, 142.34, 124.87, 124.64, 121.76, 111.66, 104.86, 
77.48, 77.16, 76.84, 53.48, 8.67; HRMS (EI+): m/z calcd for 
[C9H10N2O]




5-methoxy-3-propyl-1H-pyrrolo[3,2-b]pyridine (Table 3, Entry 
3, 4c) 
White solid (31.87mg, 67%); m. p. 55 oC; 1H NMR (499 MHz, CDCl3) 
δ 7.85 (s, 1H), 7.44-7.40 (m, 1H), 7.00 (s, 1H), 6.50 (dd, J = 8.7, 
1.8 Hz, 1H), 3.92 (s, 3H), 2.69 (t, J = 7.5 Hz, 2H), 1.75-1.67 (m, 
2H), 0.92 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 159.70, 
142.12, 124.88, 123.87, 121.52, 117.25, 105.08, 77.41, 77.16, 
76.91, 53.34, 26.29, 23.15, 14.32; HRMS (EI+): m/z calcd for 
[C11H14N2O]
+ : 190.1106, found 190.1107.  
 
Ethyl 2-(5-methoxy-1H-pyrrolo[3,2-b]pyridin-3-yl)acetate 
(Table 3, Entry 4, 4d) 
White solid (38.07mg, 65%); m. p. 50 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.31 (s, 1 H), 7.34 (d, J = 8.7 Hz, 1 H), 7.12 (s, 1 H), 6.47 (d, J 
= 8.7 Hz, 1 H), 4.13 (q, J = 7.1 Hz, 2 H), 3.89 (s, 3 H), 3.76 (s, 2 
H), 1.21 (t, J = 6.9 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 172.88, 
159.99, 141.56, 125.46, 124.45, 121.83, 108.51, 105.51, 77.41, 
77.16, 76.90, 6]0.87, 53.30, 29.64, 14.39; HRMS (EI+): m/z calcd 
for [C12H14N2O3]
+: 234.1004, found 234.1003; IR (neat): 1727cm-1.  
 
2-(5-Methoxy-1H-indol-3-yl)aniline (Scheme 2, eq 1, 6a) 
Brown oil (38.72mg, 65%); 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 
1H), 7.22-7.17 (m, 1H), 7.12 (d, J = 8.8 Hz, 1H), 7.09-7.04 (m, 
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2H), 6.93 (d, J = 2.2 Hz, 1H), 6.79 (dd, J = 8.8, 2.3 Hz, 1H), 6.76-
6.68 (m, 2H), 3.67 (s, 5H); 13C NMR (100 MHz, cdcl3) δ 154.41, 
144.74, 131.35, 131.23, 127.99, 126.83, 123.88, 120.70, 118.43, 
115.46, 114.39, 112.93, 112.25, 101.67, 77.48, 77.16, 76.84, 55.90; 
HRMS (EI+): m/z calcd for [C15H14N2O]
+: 238.1106, found 
238.1104.  
 
2-(1H-indol-3-yl)-4-methoxyaniline (Scheme 2, eq 1, 7a) 
Brown oil (12.51mg, 21%); 1H NMR (400 MHz, CDCl3) δ 8.32 (s, 
1H), 7.57 (d, J = 7.9 Hz, 1H), 7.34 (d, J = 8.1 Hz, 1H), 7.22 (s, 
1H), 7.17 (t, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.86 (s, 1H), 
6.71 (s, 2H), 3.70 (s, 3H), 3.23 (s, 2H); 13C NMR (100 MHz, CDCl3) 
δ 152.62, 138.44, 136.28, 126.49, 123.25, 123.18, 122.61, 121.89, 
120.26, 116.77, 116.60, 114.84, 113.94, 111.50, 77.48, 77.16, 
76.84, 55.92; HRMS (EI+): m/z calcd for [C15H14N2O]
+: 238.1106, 
found 238.1105.  
 
4-Chloro-2-(1H-indol-3-yl)aniline (Scheme 2, eq 2, 7b) 
Brown oil (29.73mg, 49%); 1H NMR (400 MHz, CDCl3) δ 8.21 (s, 
1H), 7.49 (d, J = 7.0 Hz, 1H), 7.32-7.26 (m, 1H), 7.19-7.10 (m, 
3H), 7.10-6.97 (m, 2H), 6.62 (dd, J = 8.4, 2.5 Hz, 1H), 3.71 (s, 
2H); 13C NMR (100 MHz, CDCl3) δ 143.41, 136.22, 130.70, 127.69, 
126.11, 123.28, 122.78, 122.74, 122.14, 120.36, 120.11, 116.49, 
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113.69, 111.58, 77.48, 77.16, 76.84; HRMS (EI+): m/z calcd for 
[C14H11ClN2]
+: 242.0611, found 242.0612.  
 
2-(5-Chloro-1H-indol-3-yl)aniline (Scheme 2, eq 2, 6b) 
Brown oil (13.35mg, 22%); 1H NMR (400 MHz, cdcl3) δ 8.26 (s, 
1H), 7.52 (s, 1H), 7.28 (d, J = 10.1 Hz, 2H), 7.19 (d, J = 5.9 Hz, 
2H), 7.12 (d, J = 7.9 Hz, 2H), 6.75 (d, J = 7.7 Hz, 2H), 3.78 (s, 
2H); 13C NMR (101 MHz, cdcl3) δ 144.78, 134.66, 131.34, 128.41, 
127.76, 126.03, 124.35, 123.00, 119.93, 119.74, 118.56, 115.56, 
114.81, 112.44, 77.48, 77.16, 76.84; HRMS (EI+): m/z calcd for 
[C14H11ClN2]
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코발트-로듐 불균일 촉매로 나이트로아릴아세토나이트릴의 환원적 고리화
반응을 통해 인돌을 합성하고 나이트로피리딜아세토나이트릴의 환원적 고
리화반응을 통해 아자인돌을 합성하하는데 성공하였다. 이 반응은 1기압의 
수소가스와 실온 (25℃)의 매우 온화한 조건에서도 다른 첨가물 없이 인돌
을 합성하는 첫 번째 연구이다. 또한 이 반응은 그램-스케일에서도 합성이 
가능함을 밝혀냈다. 이 촉매반응은 반응조건에서 매우 안정하여 10회 이상
의 재사용에도 촉매 활성을 잃지 않았다. 
 
주요어: 불균일 촉매반응, 수소화, 환원적 고리반응, 인돌, 아자인돌, 
탠덤반응, 온화한 조건 
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